Surgeon Laments Limited Availability Of Cross-Linking In US
Although UV-riboflavin collagen cross-linking is currently undergoing clinical trials in the United States, one surgeon expressed dissatisfaction that the procedure still lacks U.S. Food and Drug Administration approval for treating corneal disorders such as ectasia.